Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Danaher
NYSE:DHR Community
1
Narratives
written by author
0
Comments
on narratives written by author
103
Fair Values set
on narratives written by author
Create a narrative
Danaher
Popular
Undervalued
Overvalued
Danaher
WA
Analyst Price Target
Consensus Narrative from 25 Analysts
Future Acquisitions And Life Sciences Investments Will Secure Long-Term Success
Key Takeaways Strategic acquisitions and innovation investments position Danaher for sustained success and revenue growth in key market areas. Strong capital allocation strategies, including stock repurchases, are expected to enhance EPS and improve net margins.
View narrative
US$283.31
FV
26.6% undervalued
intrinsic discount
5.68%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
23 days ago
author updated this narrative
Your Valuation for
DHR
Danaher
Your Fair Value
US$
Current Price
US$207.95
8.0% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
31b
2015
2018
2021
2024
2025
2027
2030
Revenue US$31.2b
Earnings US$5.1b
Advanced
Set as Fair Value